Enrolling By InvitationNot applicableNCT06549088
Official study title

Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging

Study summary

This study investigates if a new imaging device can detect different types of lung tissue using spatial frequency domain imaging (SFDI). Specifically, this study aims to detect lung nodules within normal lung tissue and determine if lung nodules are cancerous. Patients who have confirmed or suspected lung nodules and who are undergoing resection of those nodules will be recruited for the study. Study participants will undergo standard of care lung nodule resection in the operating room, and the resected specimen will be imaged using the SFDI device immediately after removal from the surgical field. The data captured from the SFDI images will then be compared to the pathology findings to identify optical properties of normal and cancerous lung tissue. Because the intervention is conducted on resected biospecimens, this study yields minimal risk to participants.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedSpatial Frequency Domain Imaging

The study team can explain what participation involves.

Who it may be forLung Diseases · Cancer, Lung

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 12, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Enrolling By Invitation

Participation is limited to people invited by the study team.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of California, Irvine

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of California, Irvine
Interventions being studied
Device: Spatial Frequency Domain Imaging
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Greater than or equal to 18 years old
  • Suspected or confirmed lung nodule on diagnostic imaging
  • Undergoing lung resection using an open, endoscopic, or robotic approach
  • Standard of care orders placed for a pathology assessment of resected lung tissue
  • Adults undergoing lung resection for a lung mass
Reasons someone may not be able to joinExclusion criteria
  • \<18 years old
  • Pregnant females and incarcerated individuals
  • No standard of care orders to obtain a pathology assessment
  • RUSH pathology order for resected lung tissue
  • Any condition where the principal investigator determines to impact patient safety or quality of care

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of California, Irvine Medical CenterOrange, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 12, 2024. Always confirm current availability with the study team.

View original record ↗